Frost & Sullivan's Transformational Health Senior Consultant, Jane Andrews:
“Cell therapy is the fastest growing segment of regenerative medicine, the majority of which is stem cell therapy. It is estimated the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030. Many factors determine the rate at which the stem cell therapy market advances. It is driven by documented successes and research indicating the potential of stem cell treatments to cure life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the world's aging populations.”
If you are an interested investor that would like to learn more about Axolotl Biologix, please feel free to reach out to us through the Investors Inquiry form or by calling us at 602-334-1298.